Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced the appointment of Giovanni Galliano as General Manager for Italy. This appointment marks Avanzanite’s seventh executive leadership hire in 2025, reinforcing its vision…
The Estée Lauder Companies Inc., under the High Patronage of Mr. Emmanuel Macron, President of the French Republic, has officially opened its Fragrance Atelier within La Maison des Parfums on Rue Volney in Paris. This state-of-the-art facility represents a major…
Oticara, a clinical-stage pharmaceutical company focused on developing innovative therapies for chronic rhinosinusitis (CRS), announced encouraging Phase 2 clinical trial results for its proprietary nasal-mucosa-optimized steroid cream, OT-007B. The therapy demonstrated rapid, durable, and clinically meaningful improvements in patients with…
eClinical Solutions LLC, a global leader in digital clinical software and data management services, announced two significant achievements underscoring its commitment to advancing data science innovation. At the 2025 Society for Clinical Data Management (SCDM) Annual Conference, the company’s elluminate…
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oral small molecule therapies that target STAT3 for the treatment of fibrosis-driven diseases, announced an update on preliminary results from its Phase 2 REVERT clinical trial of TTI-101 in patients with…
Enpro Inc., a leading industrial technology company, has announced definitive agreements to acquire two strategically aligned companies — AlpHa Measurement Solutions and Overlook Industries — for a combined total of approximately $280 million in cash. These acquisitions mark a significant…
A team of scientists at Children’s Hospital Los Angeles (CHLA) has made a major breakthrough in understanding Ewing Sarcoma, a rare and aggressive cancer of the bone and soft tissue that predominantly strikes children and adolescents. Their findings provide compelling…
Arcus Biosciences, Inc., a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, announced the first overall survival (OS) results from Arm A1 of its Phase 2 EDGE-Gastric study. The trial evaluates domvanalimab, an Fc-silent anti-TIGIT antibody, in combination…
Zoetis Inc. today announced that the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of marketing authorization for Lenivia® (izenivetmab) for the reduction of pain associated with osteoarthritis…
Adagio Medical Holdings, Inc., a leading developer of catheter ablation technologies for cardiac arrhythmias, today announced preliminary acute safety and efficacy results from its FULCRUM-VT study, evaluating Ultralow Temperature Cryoablation (ULTC) for the treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)…